306 related articles for article (PubMed ID: 14606985)
1. Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications.
Al-Zakwani IS; Barron JJ; Bullano MF; Arcona S; Drury CJ; Cockerham TR
Curr Med Res Opin; 2003; 19(7):619-26. PubMed ID: 14606985
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
3. Effects of antipsychotic medication on psychiatric service utilization and cost.
Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
[TBL] [Abstract][Full Text] [Related]
4. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
Offord S; Lin J; Mirski D; Wong B
Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
[TBL] [Abstract][Full Text] [Related]
5. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
6. Factors related to antipsychotic oversupply among Central Texas Veterans.
Yang M; Barner JC; Worchel J
Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
[TBL] [Abstract][Full Text] [Related]
7. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
Sankaranarayanan J; Puumala SE
Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
[TBL] [Abstract][Full Text] [Related]
9. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization.
Jiang Y; Ni W
Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773
[TBL] [Abstract][Full Text] [Related]
10. Assessment of changes in utilization of health-care services after implementation of a prior authorization policy for atypical antipsychotic agents.
Walthour A; Seymour L; Tackett R; Perri M
Ann Pharmacother; 2010 May; 44(5):809-18. PubMed ID: 20388858
[TBL] [Abstract][Full Text] [Related]
11. Role of patient experience in atypical antipsychotic adherence: a retrospective data analysis.
Vanelli M; Coca-Perraillon M; Troxell-Dorgan A
Clin Ther; 2007 Dec; 29(12):2768-73. PubMed ID: 18201595
[TBL] [Abstract][Full Text] [Related]
12. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
13. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
14. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
15. Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics.
Pilon D; Alcusky M; Xiao Y; Thompson-Leduc P; Lafeuille MH; Lefebvre P; Benson C
J Med Econ; 2018 Feb; 21(2):135-143. PubMed ID: 28895766
[TBL] [Abstract][Full Text] [Related]
16. Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics.
Baser O; Xie L; Pesa J; Durkin M
J Med Econ; 2015 May; 18(5):357-65. PubMed ID: 25525771
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
18. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
19. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson TM; Xie J; Erder MH; Dammerman RS; Robertson B; Wu EQ
Am J Manag Care; 2014 Sep; 20(9):711-21. PubMed ID: 25365746
[TBL] [Abstract][Full Text] [Related]
20. Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study.
Steinberg SC; Faris RJ; Chang CF; Chan A; Tankersley MA
Clin Drug Investig; 2010; 30(2):89-100. PubMed ID: 20067327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
